Skip to main content

and
  1. Article

    Open Access

    Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes

    Cotadutide is a dual glucagon-like peptide 1 and glucagon receptor agonist under development for the treatment of non-alcoholic steatohepatitis and type 2 diabetes mellitus (T2DM) and chronic kidney disease. N...

    Victoria E. R. Parker, Darren Robertson, Edmundo Erazo-Tapia in Nature Metabolism (2023)